

Due to increasing healthcare expenditure, advancing vaccine technology, and rising demand for preventive vaccines, especially new COVID-19 vaccines, the Asia-Pacific preventive vaccines market will rise by 12.89% annually with a total addressable market cap of $97.2 billion between 2020 and 2026.
Coronavirus infection has recently infected millions of people all over the world. In certain areas, community transmission has resulted in an increase in global casualties. At present, Big pharma and biopharma are concentrating their efforts on COVID-19 vaccine research and development. The COVID-19 pandemic situation has generated unprecedented demand, and companies are heavily investing in R&D activities, with government support as well as technological advancement to shorten the clinical trial duration and increase production efficiency. The market's growth prospects will be bolstered by the expansion of vaccine manufacturing facilities to meet the rising demand.
Vaccine World Asia Congress 2022 will be the only vaccine-focused platform in Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the Big Pharmas, International Biopharma, Asian Biopharma, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers, and Technocrats.
With this edition of Vaccine World Asia, we have co-located with Asia-Pacific Vaccine Excellence Awards. If Asia’s vaccine business matters to you, then Vaccine World Asia Congress 2022 is the place to be!


Asia Pacific Vaccine Excellence Award applauds extraordinary leaders & trendsetters of today and inspires the innovators of tomorrow. The Awards Ceremony will be held in conjunction with the 4th Annual Vaccines World Asia Congress 2022 Virtual Conference.


In this webcast, our panellists will discuss the disruptive potential of the newly emerged mRNA platform in the vaccine industry. If it is making a big enough impact in becoming the main vaccine development platform or will become used an alternative method for rapid vaccine development.
We will discuss the main differences between the mRNA platform against other pre-existing technologies, the pros and cons, the advantages of mRNA vaccines over DNA-based vaccines (eg. shelf life, storage requirements, development timeframes), disruptive potential of mRNA platform on raw materials and vaccines supply and demand and what to expect in the international and local regulatory landscape.
This will be a great chance for you to gain insights from panellists with high level positions and expert knowledge in the vaccine industry.
Vaccine World Asia Congress will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the BIG Pharmas, International Biopharma’s, Asian Biopharmas, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccines business matters to you, then Vaccine World Asia 2022 is the place to be!
Plenary Sessions: The Future of the Vaccine Industry after COVID-19
Vaccine Manufacturing Pandemic Preparedness
Vaccine Modalities & Innovations
Innovation in Vaccine Delivery
Plenary Sessions: Covid-19 Vaccine Updates
Vaccine R&D Excellence
Vaccine Manufacturing Best Practices
Vaccine Quality & Supply Chain Management
Present your expertise to the key vaccines stakeholders from developing economies through a variety of available speaking packages.
Join the exhibition, and build an impressive presence among your potential clients.
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
Engage with and build lasting connections that matter the most to your business.
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.